Abstract. The number of studies concerning silver nanoparticles (AgNPs) has increased, due in part to their potential uses for biomedical applications. These particles have been demonstrated in the elimination of the hepatitis B virus and the inhibition of the proliferation of various cancer cells in vivo and in vitro. Thus, studies on AgNPs may lead to a more efficacious and safer therapeutic approach for chronic liver injury. Hepatic stellate cells (HSCs) are essential interstitial cells in the liver and are the predominant therapeutic target in hepatic fibrosis and liver cirrhosis; however, the intracellular effects of AgNPs on HSCs remain to be elucidated. The aim of the present study was to investigate the effects of AgNPs on the function and metabolism of HSCs. Various concentrations of AgNPs, with a diameter of 10 or 30-50 nm, were incubated with HSCs. Transmission electron microscopy, flow cytometry, enzyme-linked immunosorbent assays, and apoptosis and proliferation detection kits were used to analyze the effects of AgNPs on cell proliferation and metabolism. These studies demonstrated that AgNPs inhibited the proliferation of HSCs and induced their apoptosis in a size-and dose-dependent manner.
Introduction
Nanomaterials have been widely studied over the past decades, due to their unique chemical and physical properties. At a nanoscale, the properties of materials depend significantly on their particle size and morphology. Silver nanoparticles (AgNPs) are one of the most common commercialized nanomaterials used in key biological and medical studies for applications such as antimicrobial agents, drug and gene delivery vehicles and biosensors. (1, 2) AgNPs have been demonstrated to effectively inhibit the replication of hepatitis B virus (HBV) (3) . Injection of 10 and 50 nm diameter AgNPs into patients with HBV reduced the quantity of HBV by 40% within 10 min and by ~90% after 1 h (3). In addition, these nanoparticles have been used to target cancer cells with the controlled uptake into specific cellular compartments. Specifically, nanoparticles may be delivered to specific tissues and subcellular compartments or to malignant cells in circulation via a combination of antibody-based targeting of ligands, changing of surface charge and material composition (4) . These studies provided the basis for the prevention and cure of HBV infection and also provided a reference for chronic liver disease, such as hepatic fibrosis.
In the clinic, conventional anti-fibrotic treatments and chemotherapy are of limited success in chronic liver injury, predominantly due to non-specific drug effects and the development of drug tolerance. Thus, AgNPs may provide a more efficacious and safer therapeutic approach. The possibility of this approach is important for hepatic stellate cells (HSCs), which are considered to be targets for the therapy of hepatic fibrosis and liver cirrhosis. Thus, investigation of the cytotoxicity of AgNPs in HSCs may be useful in determining their potential use in clinical applications.
In this study, the cytotoxicity of polyvinylpyrrolidone (PVP)-coated AgNPs in primary HSCs derived from fresh rat livers was determined. The biological responses of HSCs, such as the morphological changes in subcellular structure, proliferation, apoptosis, cell movement and cytokine secretion, were determined following the treatment of cells with AgNPs. Different particle sizes and concentrations of AgNPs were also used to study their effects on the cytotoxicity of AgNPs.
Materials and methods

Preparation and characterization of AgNPs. PVP-coated
AgNPs with diameters of 10 and 30-50 nm were received in solution from Dr Jie Liu (Duke University, Durham, NC, USA). The size, morphology and dispersion of the nanoparticles were characterized using a Tecnai™ G2 Twin Transmission
In vitro cytotoxicity of silver nanoparticles in primary rat hepatic stellate cells Approximately 5x10 3 cells were plated in each well of a 96-well plate. The cells were divided into seven groups. Group 1 served as a blank control; groups 2, 3, and 4 were treated with 30-50 nm AgNPs at 20, 100 and 250 µg/ml, respectively; and groups 5, 6 and 7 were treated with 10 nm AgNPs at 20, 100 and 250 µg/ml, respectively. Following incubation for 96 h, 10 µl WST-8 was added to the wells and the absorbance at 450 nm was determined using a microplate reader (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The aforementioned samples were analyzed for 24 h.
Apoptosis detection. The FITC-Annexin V and propidium iodide (PI) double staining method was used to detect apoptosis induced by AgNPs. Freshly isolated HSCs were cultured in 96-well plates for 2 days and were divided into seven groups as described previously for the cytotoxicity studies. Following 24 h of nanoparticle treatment, the cells were washed with cold phosphate-buffered saline (4˚C) and stained using the FITC-Annexin V Apoptosis Detection kit (ExCell Biology, Inc., Shanghai, China). The stained cells were analyzed by flow cytometry by a trained laboratory technician according to the experimental protocol.
Analysis of AgNP acute toxicity by a lactase dehydrogenase (LDH) activity assay. Rat LDH kits (Sigma-Aldrich) were used to conduct the LDH leakage assay. Two days following seeding in 24-well plates, the cells were divided into two groups. One group was treated with AgNPs of different diameters and different concentrations, and the other group was treated as a control without nanoparticle treatment. The two groups were incubated at 37˚C with 5% CO 2 for 4 h according to the manufacturer's instructions. The cell culture medium (50 µl) was collected from each well and analyzed using a spectrometer (UV-Vis-NIR spectrophotometer; Agilent, Santa Clara, CA, USA).
Cell IQ. The cell biological behaviors, including the total cell number, number of dead cells and cell movement, were measured using a real-time cell-monitoring system with a cell-culturing platform (Cell-IQ; Chip-Man Technologies, Tampere, Finland). HSCs were cultured in the Cell-IQ system in 24-well plates (1x10 4 cells/well) for 72 h. Cells were divided into five groups with two wells per group. One group served as a blank control and the remaining four groups were treated with large and small AgNPs at 20 and 100 µg/ml, respectively.
Cytokine detection. The HSCs were adjusted to a concentration of 5x10 5 cells/ml and cultured in 24-well plates. The 24 wells were divided into three groups; one group served as the blank control and the other two groups were treated with AgNPs (with diameters of either 10 or 30-50 nm) at a concentration of 20 µg/ml. The conditioned medium was collected after 2 days and the quantity of hepatocyte growth factor (HGF), interleukin (IL)-6, transforming growth factor (TGF)-β1, tumor necrosis factor (TNF)-α, matrix metallopeptidase (MMP)-2 and MMP-9 in the serum-free HSC-conditioned medium was quantified using an enzyme-linked immunosorbent assay (ELISA) kit (ExCell Biology, Inc.) according to the manufacturer's instructions.
Statistical analysis.
All experiments were repeated at least three times, and the data are presented as the mean ± standard deviation. Student's t-test was performed to determine the statistical significance of the difference between untreated cells (blank control) and cells treated with AgNPs. P<0.05 was considered to indicate a statistically significant difference.
Results
Characterization of AgNPs. TEM images of the AgNPs used in this study are shown in Fig. 1 . The nanoparticles were all roughly spherical in shape, although a few aggregates were also observed. The diameters of these two types of AgNPs were 30±10 and 80±40 nm as determined by TEM. The nanoparticles consisted of C, O, N and Ag, were metallic silver with a face-centered cubic lattice and were polydispersed. The broad absorption at wavelengths >500 nm as Table I . Characterization of silver nanoparticles. Data are presented as the mean ± SD. TEM, transmission electron microscopy; DLS, dynamic light scattering; PDI, polydispersity index; ICP-MS, inductively coupled plasma mass spectrometer (Agilent, Santa Clara, CA, USA). shown in the ultraviolet-visible absorption spectra also indicated the possible existence of aggregates (Fig. 1) . The results of the other characterization experiments are summarized in Table I .
Identification of HSCs. Approximately 2x10
7 HSCs were isolated from each rat. The morphology of freshly isolated HSCs exhibited no obvious features ( Fig. 2A) . Abundant lipid droplets were observed with light microscopy and the cyan vitamin A autofluorescence was excited at 328 nm, as observed with fluorescence microscopy (Fig. 2B) . However, activated HSCs demonstrated star-like morphology (Fig. 2C ) and developed into fibroblast-like cells 7 days following isolation (Fig. 2D) . More than 95% of the HSCs showed positive desmin staining, indicating that the population consisted of pure HSCs (Fig. 2E and F) . In addition, >95% of the HSCs were positive for α-SMA, also suggesting a pure population ( Fig. 2G and H) .
Ultrastructural characteristics of AgNP-treated HSCs.
According to the TEM analysis, AgNPs were rapidly internalized by HSCs, although the majority of the nanoparticles were observed on the cell surface and between the cells (Fig. 3A) . The TEM images of AgNP-treated cells demonstrated the presence of electron-dense, aggregated regions, which were thought to be AgNPs in the cytoplasm (Fig. 3B) . Moreover, AgNP-treated HSCs exhibited karyolysis and ruptured cell membranes (Fig. 3C) . The presence of large vacuoles and the swelling of the mitochondria indicated the destruction of organelles in the treated cells (Fig. 3D) .
Apoptosis detection.
To investigate the mechanism of cell death induced by AgNPs, the treated cells were stained with FITC-Annexin V and PI. The smaller AgNPs exhibited a greater ability to induce apoptosis and necrosis in the HSCs than the larger AgNPs (Fig. 4A) . Morever, treatment of HSCs with higher concentrations of AgNPs induced greater rates of apoptosis and necrosis than the lower concentrations of AgNPs. Cell death was primarily due to a size-dependent increase in apoptosis induced by the smaller AgNPs. In addition, the large and small AgNPs induced greater apoptosis than necrosis in treated HSCs (Fig. 4Aa) . Notably, AgNPs induced the greatest apoptosis and the least necrosis at the highest concentration tested (250 µg/ml). Fig. 4B ). Thus, the HSC death was not able to be correlated with the acute toxicity of AgNPs. The aforementioned results also indicated the primary cause of HSC death was not due to the acute toxicity of AgNPs.
In vitro cytotoxicity of AgNPs. The time-dependent cytotoxicity of AgNPs was assessed using the CCK-8 assay (Fig. 4C) . HSC growth was arrested in the presence of the two sizes of nanoparticles at various concentrations. The influence of particle size and concentration on cell proliferation was determined. Treatment of cells with 100 µg/ml AgNPs resulted in a decrease in cell proliferation after 96 h of exposure. These effects were also dependent on the AgNP diameter size. In particular, the smaller nanoparticles induced a greater decrease in cell viability than larger ones. Furthermore, in cases of treatment with identically sized nanoparticles, there was a greater inhibitory effect with an increased concentration.
Inhibitory effects of AgNPs on cell biological behaviors.
Dynamic alterations of the total cell number, number of dead cells and cell movement were measured using a Cell-IQ culturing platform. The increased percentage of the total cell number was significantly lower following incubation with AgNPs, than in untreated cells (P<0.05). The inhibitory effects of AgNPs were dependent on the size and dose (Fig. 5Bc) . The number of dead cells as a percentage of total cells in the control group was significantly lower than that in the groups treated with AgNPs (P<0.05), and the effect was dose-and size-dependent (Fig. 5Ba) . Similarly, the movement of AgNP-treated HSCs was inhibited (P<0.05). The diameter of the AgNPs, however, was not significantly correlated with cell migration at high concentrations (P>0.05).
Effect of AgNPs on various cytokines.
Analysis of cytokine levels following treatment of HSCs with AgNPs was performed using ELISA. Production of HGF, IL-6, TGF-β1, and TNF-α was not significantly different between the treated and untreated groups (Fig. 6 ). The cells treated with AgNPs produced less MMP-2 and MMP-9 than the control cells (P<0.05).
Discussion
Previously, AgNPs have been studied as a result of their ability to inhibit HBV and their function in drug delivery and targeting, which may lead to their application for treating liver diseases (1, 6, 7) . With such considerable interest in the development of AgNPs for medical applications, there is concern regarding their cytotoxicity and its potential mechanism of action. Consequently, this study investigated the cytotoxic effects of AgNPs on HSCs. The study demonstrated three key results: i) the AgNPs exerted a strong negative effect on HSCs, even at low concentration; ii) the particle size of the AgNPs affected the cytotoxicity, as the smaller nanoparticles exerted larger effects on cell bioactivity than the larger nanoparticles; and iii) AgNPs altered the secretion of cytokines by HSCs, which may further affect the microenvironment of HSC activation. Previous studies have demonstrated the impact of nanoparticle size on cellular uptake and consequent cytotoxicity (8, 9) . In the present study, the cytotoxic effects of AgNPs, according to their size and concentration, were determined by the investigation of AGNPs of two distinct sizes at various concentrations. The results of the CCK-8 assay demonstrated that the cytotoxic effects exerted by AgNPs on HSCs are sizeand dose-dependent. Smaller AgNPs induced greater HSC cytotoxicity than the larger particles, and at higher concentrations, these nanoparticles induced greater apoptosis. The death of HSCs was not due to acute toxicity, according to our studies, which confirmed the relatively safe use of HSCs in vivo. Morever, the mechanism of cell death induced by AgNPs was analyzed and it was demonstrated that the cell death of AgNP-treated HSCs was predominantly due to apoptosis. The induced HSC apoptosis primarily occurred in cells treated with the smaller nanoparticles and the apoptotic behavior was dose dependent. To enter the cell nucleus, nanoparticles must be small enough to pass through the nuclear pore complex on the nuclear membrane. The size of AgNPs is therefore significant in cellular uptake, and thus may impact their bioactivity (10) . As a result, consideration of the particle size is required in the design of nanoparticles for biomedical uses.
The changes in HSC morphology were studied using phase contrast microscopy and TEM prior to and following incubation with two sizes of AgNPs at various concentrations. These studies indicated that AgNPs induced HSCs apoptosis or necrosis. The ultrastructural characteristics of apoptosis are cell shrinkage, karyopyknosis, karyorrhexis and karyolysis. Karyorrhexis is a type of destructive fragmentation of the nucleus and is preceded by pyknosis and followed by karyolysis (11) . This fragmentation appeared predominantly in HSCs treated with 250 µg/ml of smaller AgNPs (Fig. 3C) . Karyotheca disintegration followed by karyolysis is the complete dissolution of the chromatin matter of a dying cell. Cell membrane rupture and the eventual fragmentation of the cell into apoptotic bodies that are engulfed by neighboring cells or phagocytes was observed in HSCs treated with AgNPs (12) . The cellular uptake of smaller nanoparticles may be easier than the uptake of larger nanoparticles, although this hypothesis requires additional confirmation by quantitative analysis. Necrosis, however, occurs when the cell is sacrificed and is characterized by cell swelling, cell organelle swelling and the formation of microvesicles (Fig. 3D ). This cellular swelling may be accompanied by an increase in intracellular pressure that leads to the breakage of the cell membrane, which allows leakage of the cytoplasm into the intercellular space (13) .
The mitochondrial swelling observed following incubation of HSCs with AgNPs indicated that the AgNPs in the cytoplasm primarily reside in the mitochondria, affecting their function and consequently exerting effects on cell metabolism. Mitochondria are important signaling centers during apoptosis, and the loss of mitochondrial integrity is induced and inhibited by numerous regulators of apoptosis (14) . For example, Bcl-2 prevents the opening of the mitochondrial membrane pore, whereas Bax accelerates this opening (15) . AgNPs have been demonstrated to activate the intrinsic apoptotic pathway, which is characterized by the modulation of Bax and Bcl-2 expression, disruption of the mitochondrial membrane potential, and cytochrome c release from the mitochondria (16) . During the apoptotic process, the mitochondrial membrane pores are opened and the mitochondrial membrane potential is disrupted (17) . Loss of mitochondrial membrane potential is followed by cytochrome c release from the mitochondria, resulting in the activation of caspase-9 and -3.
Activated HSCs are important in chronic liver disease through the production of various cytokines. The ELISA assay confirmed that AgNPs inhibited the production of MMP-2 and -9, which are known to be crucial in chronic liver injury. During hepatic inflammation and hepatocellular necrosis, MMP-2 and -9 are predominantly produced by myofibroblasts, which transdifferentiate from activated HSCs (18) . In chronic liver disease, increases in MMP-2 and -9 are associated with fibrosis and the development of cirrhosis through altered matrix production and degradation (19) . In addition, the overexpression of MMP-2 and -9 has been detected in hepatocellular carcinoma (HCC) (20) . Moreover, the overexpression of MMP-2 and -9 in HCC tissues is correlated with liver cirrhosis, capsular invasion, the presence of intrahepatic metastasis, vascular invasion and higher tumor-node-metastasis stage (20) . Therefore, the inhibitory effects of AgNPs on certain cytokines may destroy the microenvironment in hepatic fibrosis and cirrhosis; however, the detailed mechanisms require further investigation.
In conclusion, the cytotoxicity of AgNPs was investigated by various biochemical approaches and was particle size-and dose-dependent. Morphology alterations may be an indication of metabolic and structural disturbances of HSCs caused by AgNPs. Thus, it was concluded that these alterations were size-dependent, as smaller particles induced greater cellular damage at the same concentrations. The results of the LDH assay confirmed that the necrosis or apoptosis of HSCs was not due to the acute toxicity of AgNPs but due to the effects of the nanoparticles on the physiological activities of the cells. These findings may illustrate the relative safety of AgNP application to the human body. AgNPs also affected the HSC cytokine secretion, as demonstrated by the inhibitory effects of AgNPs on the production of MMP-2 and -9. These results suggested that AgNPs may be used in the treatment of hepatic fibrosis, including HCC; however, the molecular mechanisms of nanoparticle cytotoxicity remain unclear. Therefore, further studies are required to elucidate particle-cell interactions and the metabolic and immunological responses activated in HSCs in the presence of AgNPs.
